{
    "2018-08-21": [
        [
            {
                "time": "",
                "original_text": "主打产品连遭降价市值蒸发四成 贝达药业多位股东集中减持 连续下跌",
                "features": {
                    "keywords": [
                        "主打产品",
                        "降价",
                        "市值蒸发",
                        "贝达药业",
                        "股东减持",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[优于大市评级] 医药与健康护理行业深度报告：震荡格局下 如何看待医药板块未来",
                "features": {
                    "keywords": [
                        "优于大市评级",
                        "医药",
                        "健康护理",
                        "行业深度报告",
                        "震荡格局",
                        "医药板块未来"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康护理"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}